PAVmed Inc.

Historical 13F Holders

Symbol
PAVM
CUSIP
70387R403
All holders as of
Q4 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 70387R403 since 12/18/2024, largest first.

Filer % of Class Filed
Ayrton Capital LLC 13G/A
9.9% 2/13/2025
Event 12/31/2024
First Manhattan Co. LLC. 13G
9.6% 5/14/2026
Event 3/31/2026
Sargent Investment Group, LLC 13G 5.8% 8/14/2025
Event 7/1/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Tasso Partners, LLC 13G
Amended under CUSIP 70387R502 on 4/3/2026
18.9% 2/28/2025
Event 2/21/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q4 28 1.92 M $426 k
2025 Q3 36 1.58 M $2.95 M
2025 Q2 32 1.23 M $735 k
2025 Q1 34 1.21 M $873 k
2024 Q4 27 1.04 M $654 k
2024 Q3 24 1.12 M $1.38 M
2024 Q2 29 1.10 M $936 k
2024 Q1 28 963 k $2.04 M
2023 Q4 32 756 k $3.12 M